Jump to navigation Jump to content

RoslinCT to establish a Cell and Gene Training Academy


RoslinCT a cell and gene therapy/ATMP Contract Development and Manufacturing Organization (CDMO), announce establishment of the RoslinCT Training Academy as part of expansion plans to further develop a skilled team and support company growth.

The fitting out of the Academy, located within a new state of the art facility on Edinburgh BioQuarter, is progressing well and will focus on upskilling existing staff as well as providing external training as part of the UK Advanced Therapies Skills Training Network (ATSTN).

As RoslinCT move through this phase of growth, they are developing a team and infrastructure to create high-value and develop potentially lifesaving treatments.

Together with the Training Academy, RoslinCT has been selected to be leading the Scottish Group as one of three preferred bidders for National Training Centres, to deliver ATMP and Vaccine-specific on-site training courses, as part of the ATSTN.

Janet Downie, CEO of RoslinCT said: “ With Cell and Gene Therapy Manufacturing being at the cutting edge we have taken the strategy to provide the training internally and develop a highly-skilled RoslinCT team. We are delighted to be part of the ATSTN network and be able to share our knowledge more widely. With the tremendous growth in ATMP and Vaccine Manufacturing, we are proud to support a pipeline of talent to support the industry for Scotland and the UK.”

The new Training Academy is supported by Scottish Enterprise, with £100,000 in grant funding provided as a contribution towards fully equipping the new facility. David Leven, Head of High Value Manufacturing at Scottish Enterprise, said: “ Despite the Covid-19 pandemic, the cell and gene therapy sector has continued to grow and prosper, with demand for manufacturing capacity continuing to increase.

“ It’s fantastic to see RoslinCT expand its manufacturing facilities and create this new training academy, which will benefit all of Scotland’s cell and gene therapy companies and enhance our global reputation for life sciences excellence.”


Read more about RoslinCT’s ambitious plans for growth as the company prepares to open a new additional facility on Edinburgh BioQuarter.

RoslinCT unveils expansion plans at Edinburgh BioQuarter